Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: A comparison with isoflurane

Anesthesia and Analgesia

Volumn 103, Issue 3, 2006, Pages 527-532

  Xia, Zhengyuan ^a,c   Huang, Zhiyong ^a,b   Ansley, David M ^c  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Shenzhen Sun Yat sen Cardiovascular Hospital   (China)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; ISOFLURANE; MALONALDEHYDE; MIDAZOLAM; PANCURONIUM; PROPOFOL; TROPONIN I; BIOLOGICAL MARKER; INTRAVENOUS ANESTHETIC AGENT;

ADULT; AGED; ANESTHESIA INDUCTION; ANTIOXIDANT ACTIVITY; AORTA CLAMPING; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY SURGERY; DIAGNOSTIC KIT; DRUG MEGADOSE; FEMALE; HEART INDEX; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC VASCULAR RESISTANCE; ANESTHESIA; AORTA; COMPARATIVE STUDY; DRUG EFFECT; HEART; HEART MUSCLE; INTRAVENOUS ANESTHESIA; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

AGED; ANESTHESIA; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INTRAVENOUS; AORTA; BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; HEART; HUMANS; ISOFLURANE; MIDDLE AGED; MYOCARDIUM; PROPOFOL;

EID: 33749041982     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000230612.29452.a6     Document Type: Article

References (30)

1. Kevin LG, Katz P, Camara AK, et al. Anesthetic preconditioning: effects on latency to ischemic injury in isolated hearts. Anesthesiology 2003;99:385-91.
2. Tanaka K, Kehl F, Gu W, et al. Isoflurane-induced preconditioning is attenuated by diabetes. Am J Physiol Heart Circ Physiol 2002;282:H2018-23.
3. Kehl F, Krolikowski JG, Mraovic B, et al. Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology 2002;96:183-8.
4. Toufektsian MC, Boucher FR, Tanguy S, et al. Cardiac toxicity of singlet oxygen: implication in reperfusion injury. Antioxid Redox Signal 2001;3:63-9.
5. Clermont G, Vergely C, Jazayeri S, et al. Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass. Anesthesiology 2002;96:80-7.
6. Ansley DM, Xia Z, Dhaliwal BS. The relationship between plasma free 15-F2t-isoprostane concentration and early postoperative cardiac depression following warm heart surgery. J Thorac Cardiovasc Surg 2003;126:1222-3.
7. Xia Z, Godin DV, Ansley DM. Propofol enhances ischemic tolerance of middle-aged rat hearts: effects on 15-F(2t)-isoprostane formation and tissue antioxidant capacity. Cardiovasc Res 2003;59:113-21.
8. Xia Z, Godin DV, Ansley DM. Application of high-dose propofol during ischemia improves postischemic function of rat hearts: effects on tissue antioxidant capacity. Can J Physiol Pharmacol 2004;82:919-26.
9. Ansley DM, Sun J, Visser WA, et al. High dose propofol enhances red cell antioxidant capacity during CPB in humans. Can J Anaesth 1999;46:641-8.
10. Xia Z, Gu J, Ansley DM, et al. Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease. J Thorac Cardiovasc Surg 2003;126:1404-10.
11. Xia ZY, Liu XY, Zhan LY, et al. Ginsenosides compound (shen-fu) attenuates gastrointestinal injury and inhibits inflammatory response after cardiopulmonary bypass in patients with congenital heart disease. J Thorac Cardiovasc Surg 2005;130:258-64.
12. Murphy PG, Myers DS, Davies MJ, et al. The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth 1992;68:613-8.
13. Xia Z, Godin DV, Chang TK, Ansley DM. Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F2t-isoprostane formation. Can J Physiol Pharmacol 2003;81:14-21.
14. Ko SH, Yu CW, Lee SK, et al. Propofol attenuates ischemia-reperfusion injury in the isolated rat heart. Anesth Analg 1997;85:719-24.
15. Kokita N, Hara A, Abiko Y, et al. Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts. Anesth Analg 1998;86:252-8.
16. Sayin MM, Ozatamer O, Tasoz R, et al. Propofol attenuates myocardial lipid peroxidation during coronary artery bypass grafting surgery. Br J Anaesth 2002;89:242-6.
17. De Hert SG, ten Broecke PW, Mertens E, et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002;97:42-9.
18. Conzen PF, Fischer S, Detter C, Peter K. Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology 2003;99:826-33.
19. Belhomme D, Peynet J, Louzy M. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999;100:II340-4.
20. Lerman J. Study design in clinical research: sample size estimation and power analysis. Can J Anaesth 1996;43:184-91.
21. Lim W, Qushmaq I, Cook DJ, et al. Elevated troponin and myocardial infarction in the intensive care unit: a prospective study. Crit Care 2005;9:R636-44.
22. De Hert SG, Van der Linden PJ, Cromheecke S, et al. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 2004;101:9-20.
23. Fellahi JL, Gue X, Philippe E, et al. Isoflurane may not influence postoperative cardiac troponin I release and clinical outcome in adult cardiac surgery. Eur J Anaesthesiol 2004;21:688-93.
24. Riess ML, Kevin LG, McCormick J, et al. Anesthetic preconditioning: the role of free radicals in sevoflurane-induced attenuation of mitochondrial electron transport in Guinea pig isolated hearts. Anesth Analg 2005;100:46-53.
25. Das DK, Maulik N, Sato M, Ray PS. Reactive oxygen species function as second messenger during ischemic preconditioning of heart. Mol Cell Biochem 1999;196:59-67.
26. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 1997;29:207-16.
27. Tomasdottir H, Hjartarson H, Ricksten A. Tumor necrosis factor gene polymorphism is associated with enhanced systemic inflammatory response and increased cardiopulmonary morbidity after cardiac surgery. Anesth Analg 2003;97:944-9.
28. Luo T, Xia Z, Ansley DM, et al. Propofol dose-dependently reduces TNF-alpha induced human umbilical vein endothelial cell apoptosis: effects on bcl-2 and bax expression and nitric oxide generation. Anesth Analg 2005;100:1653-9.
29. Scarabelli T, Stephanou A, Rayment N, et al. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 2001;104:253-6.
30. Lim KH, Halestrap AP, Angelini GD, Suleiman MS. Propofol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass. Exp Biol Med (Maywood) 2005;230:413-20.